Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- The FDA has approved Oyster Point Pharma Inc (NASDAQ:OYST) Tyrvaya (varenicline solution) Nasal Spray 0.03 mg for signs and symptoms of dry eye disease.
- Tyrvaya Nasal Spray is the first and only nasal spray approved for dry eye disease.
- Related: Oyster Point Inks License Pact With Ji Xing Pharma For Dry Eye Disease Candidates In Greater China.
- Tyrvaya binds to cholinergic receptors to activate the trigeminal parasympathetic pathway resulting in increased production of the basal tear film as a treatment for dry eye disease.
- Tyrvaya will be available from next month in cartons containing two multidose nasal spray bottles.
- Each nasal spray bottle covers treatment for 15 days, administered twice daily into each nostril.
- Related content: Benzinga's Full FDA Calendar.
- Price Action: OYST shares closed 1.91% higher at $13.86 on Monday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!